Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,429 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dupilumab improves clinical and histologic features of eosinophilic esophagitis prior to 12 weeks of treatment.
Sia T, Miller A, Bacchus L, Young J, Narayan AP, Solecki R, Fu J, Jiang Y, Khuda R, Liu S, Love K, Mallik S, Matmatte AS, McDonald P, Telukunta T, Roby A, Shami S, Zheng M, Headen M, Leung J. Sia T, et al. Among authors: zheng m. Clin Transl Allergy. 2024 Jan;14(1):e12333. doi: 10.1002/clt2.12333. Clin Transl Allergy. 2024. PMID: 38282196 Free PMC article. No abstract available.
Clinical and histologic remission achieved with upadacitinib in a patient with refractory eosinophilic gastritis and duodenitis.
Fu J, Sia T, Solecki R, Mallik S, Khuda R, Headen M, Bacchus L, Zheng M, Telukunta T, Shami S, Liu S, Sureshbabu S, Love K, Roby A, McDonald P, Jiang Y, Narayanan DH, Cunningham E, Matmatte AS, Tan PE, Leung J. Fu J, et al. Among authors: zheng m. J Allergy Clin Immunol Pract. 2024 Jun;12(6):1649-1651. doi: 10.1016/j.jaip.2024.02.031. Epub 2024 Feb 27. J Allergy Clin Immunol Pract. 2024. PMID: 38423296 Free article. No abstract available.
Corrigendum to "Electrically-driven drug delivery into deep cutaneous tissue by conductive microneedles for fungal infection eradication and protective immunity" [Biomaterials 314 (2025) 122908].
Ghosh S, Zheng M, He J, Wu Y, Zhang Y, Wang W, Shen J, Yeung KWK, Neelakantan P, Xu C, Qiao W. Ghosh S, et al. Among authors: zheng m. Biomaterials. 2024 Nov 28:122973. doi: 10.1016/j.biomaterials.2024.122973. Online ahead of print. Biomaterials. 2024. PMID: 39613707 No abstract available.
Proteolethargy is a pathogenic mechanism in chronic disease.
Dall'Agnese A, Zheng MM, Moreno S, Platt JM, Hoang AT, Kannan D, Dall'Agnese G, Overholt KJ, Sagi I, Hannett NM, Erb H, Corradin O, Chakraborty AK, Lee TI, Young RA. Dall'Agnese A, et al. Among authors: zheng mm. Cell. 2024 Nov 25:S0092-8674(24)01274-1. doi: 10.1016/j.cell.2024.10.051. Online ahead of print. Cell. 2024. PMID: 39610243
9,429 results